Viewing nowMemantigen Tablets (Memantine Hydrochloride)
Memantine Hydrochloride 10mg
Tablet · Prescription medication
Celix Co., Ltd.

MFDS item code 201903735 · Approved 2019.06.04 · Insurance code 646204060
Treatment of moderate to severe Alzheimer's disease
This medication is used for the treatment of moderate to severe Alzheimer's disease.
Treatment must be initiated by a physician experienced in the diagnosis and treatment of Alzheimer's dementia, and only if a caregiver is able to periodically check that the patient is taking the medicine. The diagnosis should be made according to currently accepted guidelines. The clinical benefit of this medicine and the patient's tolerability of treatment should be reassessed periodically. This medicine may be taken with or without food. Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (Day 1–7): Administer 5mg once daily for 7 days. Week 2 (Day 8–14): Administer 10mg daily (5mg twice daily) for 7 days. Week 3 (Day 15–21): Administer 15mg daily (10mg in the morning and 5mg in the evening) for 7 days. From Week 4 onward: Administer 20mg daily (10mg twice daily). Maintenance dose: The recommended maintenance dose is 20mg daily (10mg twice daily). Based on clinical data, the recommended dose for older patients aged 65 years or older is 20mg daily (10mg twice daily). No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-50 mL/min), the daily dose should be reduced to 10mg. If the dose is well tolerated after at least 7 days of treatment, it may be increased to 20mg daily according to the standard dose-escalation method. In patients with severe renal impairment (creatinine clearance 5-30 mL/min), the daily dose should be reduced to 10mg. No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since no data are available on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.
This medication should not be used in patients with hypersensitivity to its constituents or those with severe liver or kidney dysfunction. Patients with a history of seizures or convulsions, or those who are prone to seizures should be particularly cautious when using this medication. Concurrent use of NMDA antagonists, which are drugs of the same class, may increase or prolong side effects, so co-administration should be avoided. Patients with changes in urine acidity or heart-related diseases should be monitored closely when using this medication. Symptoms such as dizziness, headache, constipation, drowsiness, and hypertension may occur with the use of this medication, and if abnormal symptoms arise, consultation with a healthcare professional should be sought. Psychiatric side effects such as confusion, hallucinations, and psychotic reactions may rarely occur, so caution is needed. This medication may interact with other drugs, so if you are currently taking any other medications, be sure to inform your healthcare provider. Women who are pregnant or may become pregnant must carefully consider the risks and benefits of using this medication, and breastfeeding should ideally be discontinued if using this medication. The safety and efficacy of this medication have not been confirmed in children and adolescents under 18 years of age. In case of overdose, central nervous system symptoms or gastrointestinal symptoms may appear, so it is essential to visit a medical facility immediately for appropriate treatment. This medication is used for patients with severe Alzheimer's disease, and since their responsiveness may be reduced, special caution should be exercised when driving or operating machinery. This medication should be stored out of the reach of children, and transferring it to another container should be avoided as it may not be good for maintaining the quality.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. Additionally, it is important to maintain a storage temperature between 1 to 30 degrees Celsius to preserve its effectiveness.
White rectangular film-coated tablets
- - 30 tablets/bottle, - - 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMemantine Hydrochloride 10mg
Tablet · Prescription medication
Celix Co., Ltd.
Memantine Hydrochloride 1g
Solution · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Unimed Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Myongin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.